RxSight, Inc. reported $30.9 million in sales for Q1 2026, driven by 27,472 Light Adjustable Lens units, though sales declined 18.5% year-over-year mainly due to fewer Light Delivery Devices sold. The company highlighted strong clinical data at the ASCRS meeting and gained regulatory approval in New Zealand, expanding its global reach. Despite a net loss of $15.9 million in Q1, RxSight reaffirmed its 2026 revenue guidance of $120 to $135 million and expects operating expenses at the high end of its previous range due to strategic investments. The company remains focused on commercial initiatives and technology development to build momentum.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Frasers Group PLC has withheld financial guidance for the upcoming year due to uncertainty around its takeover bids for Hugo Boss and Accent Group. The retailer's full-year adjusted profit before tax fell 4% to £538 million, impacted by asset impairm...
Ethereum rose 3.17% to $1,923.53, outperforming Bitcoin's modest 0.18% gain to $64,588.87, signaling an early rotation toward large-cap altcoins. Despite this, overall market activity slowed, with declines in DeFi, stablecoin, and derivatives trading...
Gabriel Holding A/S has agreed to sell its European FurnMaster furniture manufacturing operations, including subsidiaries in Poland and Lithuania, to Leggett & Platt for an initial price of approximately EUR 9 million, with a possible additional paym...
A Gaza resident raised over £55,000 on GoFundMe to support his family but faced issues as the platform cannot pay directly to Gaza, forcing funds through intermediaries who failed to deliver the full amount. This highlights a broader problem in human...
